Latest venBio Partners LLC Stock Portfolio
venBio Partners LLC Performance:
2025 Q4: 25.43%YTD: 26.25%2024: -53.75%
Performance for 2025 Q4 is 25.43%, and YTD is 26.25%, and 2024 is -53.75%.
About venBio Partners LLC and 13F Hedge Fund Stock Holdings
On 2026-02-17, the fund reported it's updated stock portfolio. In the 13F Holdings report, venBio Partners LLC reported an equity portfolio of $216.3 Millions as of 31 Dec, 2025.
The top stock holdings of venBio Partners LLC are PHVS, , HRMY. The fund has invested 59.5% of it's portfolio in PHARVARIS N V and 20.9% of portfolio in ALUMIS INC.
They significantly reduced their stock positions in ARTIVA BIOTHERAPEUTICS INC and LYELL IMMUNOPHARMA INC (LYEL).
The top stock holdings of venBio Partners LLC are PHVS, , HRMY. The fund has invested 59.5% of it's portfolio in PHARVARIS N V and 20.9% of portfolio in ALUMIS INC.
They significantly reduced their stock positions in ARTIVA BIOTHERAPEUTICS INC and LYELL IMMUNOPHARMA INC (LYEL).
venBio Partners LLC Annual Return Estimates Vs S&P 500
Our best estimate is that venBio Partners LLC made a return of 25.43% in the last quarter. In trailing 12 months, it's portfolio return was 26.25%.
- Performance
- S&P 500
New Buys
Additions
Reductions
| Ticker | % Reduced |
|---|---|
| artiva biotherapeutics inc | -43.56 |
| lyell immunopharma inc | -28.68 |
venBio Partners LLC reduced stake in above stock
Sold off
Sector Distribution
venBio Partners LLC has about 81.7% of it's holdings in Others sector.
- Others
- Healthcare
| Sector | % |
|---|---|
| Others | 81.7 |
| Healthcare | 18.3 |
Market Cap. Distribution
venBio Partners LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
- UNALLOCATED
- MID-CAP
- MICRO-CAP
- SMALL-CAP
| Category | % |
|---|---|
| UNALLOCATED | 81.7 |
| MID-CAP | 8.5 |
| MICRO-CAP | 5.1 |
| SMALL-CAP | 4.8 |
Stocks belong to which Index?
About 18.3% of the stocks held by venBio Partners LLC either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| Others | 81.7 |
| RUSSELL 2000 | 18.3 |
venBio Partners LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of venBio Partners LLC
venBio Partners LLC has 6 stocks in it's portfolio. ALXO proved to be the most loss making stock for the portfolio. was the most profitable stock for venBio Partners LLC last quarter.
Last Reported on: 17 Feb, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ALXO | alx oncology hldgs inc | 5.07 | 9,699,920 | 10,960,900 | unchanged | 0.00 | ||
| HRMY | harmony biosciences hldgs in | 8.46 | 489,194 | 18,305,600 | unchanged | 0.00 | ||
| LYEL | lyell immunopharma inc | 4.81 | 337,697 | 10,394,300 | reduced | -28.68 | ||
| PHVS | pharvaris n v | 59.53 | 4,639,300 | 128,741,000 | unchanged | 0.00 | ||
| alumis inc | 20.85 | 4,619,800 | 45,089,300 | unchanged | 0.00 | |||
| artiva biotherapeutics inc | 1.29 | 648,507 | 2,782,100 | reduced | -43.56 | |||